Skip to main content
Signal8
Fredrickson David Paul profile photo

David Paul Fredrickson

CIK: 0002071948

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Caris Life Sciences, Inc. logo
CAI

Caris Life Sciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Caris Life Sciences, Inc. logo
    CAI

    Caris Life Sciences, Inc.

    Aug 14, 2026
    Award(A)
    Direct
    13.2K shares-
  • Caris Life Sciences, Inc. logo
    CAI

    Caris Life Sciences, Inc.

    Feb 26, 2026
    Award(A)
    Direct
    2.5K shares at avg. $20.06$50K

1-2 of 2

About Fredrickson David Paul

Fredrickson David Paul (SEC CIK 0002071948) files insider reports with the SEC as Director of Caris Life Sciences, Inc. (CAI).

Signal8 holds 3 ownership filings by Fredrickson David Paul (1 Form 3, 2 Form 4), filed between Jun 17, 2025 and Aug 14, 2026. Those filings report 2 transactions, from Feb 26, 2026 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Fredrickson David Paul's filings is in IRVING, TX.

Recent filings by Fredrickson David Paul

  • Aug 14, 2026: Grant or award of CAI shares (Form 4, code A).
  • Feb 26, 2026: Grant or award of CAI shares (Form 4, code A).

Other insiders filing for Caris Life Sciences, Inc. (CAI)

How to read Form 4 transaction codes